These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis. Winter HS; Landers CJ; Winkelstein A; Vidrich A; Targan SR J Pediatr; 1994 Nov; 125(5 Pt 1):707-11. PubMed ID: 7965422 [TBL] [Abstract][Full Text] [Related]
44. Rectal complications of inflammatory disease of the small and large bowel. CROHN BB Dis Colon Rectum; 1960; 3():99-102. PubMed ID: 13812932 [No Abstract] [Full Text] [Related]
45. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases. Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978 [TBL] [Abstract][Full Text] [Related]
46. Antioxidant defense in erythrocytes and plasma of patients with active and quiescent Crohn disease and ulcerative colitis: a chemiluminescent study. Blázovics A; Kovács A; Lugasi A; Hagymási K; Bíró L; Fehér J Clin Chem; 1999 Jun; 45(6 Pt 1):895-6. PubMed ID: 10351999 [No Abstract] [Full Text] [Related]
47. Increased serum levels of eotaxin in patients with inflammatory bowel disease. Chen W; Paulus B; Shu D; Wilson ; Chadwick V Scand J Gastroenterol; 2001 May; 36(5):515-20. PubMed ID: 11346206 [TBL] [Abstract][Full Text] [Related]
48. Pulmonary function abnormalities in patients with inflammatory bowel disease. Heatley RV; Thomas P; Prokipchuk EJ; Gauldie J; Sieniewicz DJ; Bienenstock J Q J Med; 1982; 51(203):241-50. PubMed ID: 7146309 [No Abstract] [Full Text] [Related]